medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2009, Número 11-12

<< Anterior Siguiente >>

Medicina & Laboratorio 2009; 15 (11-12)


Estudio del paciente con talla baja

Lopera CMV, Campuzano MG, Balthazar GV, Alfaro VJM

Idioma: Español
Referencias bibliográficas: 73
Paginas: 511-531
Archivo PDF: 968.87 Kb.


RESUMEN

La talla baja se define como la condición en la cual la altura de un niño o niña es más de dos desviaciones estándar por debajo del promedio poblacional esperado para su edad y sexo, o por debajo del percentil 3. La talla baja es una de las principales causas por las cuales se consulta al pediatra endocrinólogo; sin embargo, hay que tener presente que existen variaciones normales en el crecimiento que deben ser diferenciadas de las patológicas. Es necesario que la evaluación del paciente con talla baja incluya una historia clínica completa y detallada, un cuidadoso examen clínico, auxología y pruebas diagnósticas, incluyendo evaluaciones radiológicas, con el fin de diferenciaraquellos pacientes con crecimiento patológico de aquellos pacientes normales con talla baja. Esta revisión analiza los factores que influyen en el crecimiento, las bases de una evaluación apropiada del crecimiento y las pruebas diagnósticas para el estudio del paciente con la talla baja.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008; 93: 4210-4217.

  2. Rosenfeld RH, Cohen P. Disorders of growth hormone/ insulin-like growth factors secretion and action. In: Sperling MA, ed. Pediatric endocrinology. 3rd ed. Philadelphia, WB Saunders. 2008: 211- 288.

  3. Kroeneberg H, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology, 11th ed Saunders. 2007.

  4. Martha PM, Jr., Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys.J Clin Endocrinol Metab 1989; 69: 563-570.

  5. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991; 72: 51-59.

  6. Delbert AF. Endocrinology test selection and interpretation. In: The quest diagnostics manual. 4a ed. Paperback. 2007.

  7. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995; 80: 1532-1540.

  8. Shah A, Stanhope R, Matthew D. Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 1992; 304: 173-174.

  9. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3993.

  10. Pérez-Sánchez PL, Medrano-Ortiz de Zárate ME, Reza-Albarrán A. Pruebas diagnósticas en endocrinología. Sociedad Mexicana de Nutricion y Endocrinología. México, 2008.

  11. Pombo-Arias M. Tratado de endocrinología pediátrica. 2 ed. Editorial Diaz de Santos. Santiago de Compostela, 1997.

  12. Calzada-León R. Identificación y manejo del niño con talla baja. México, 2007.

  13. Bidder C, Warner JT. Assessment of the short child. Paediatrics and Child Health 2009; 19: 522- 528.

  14. Dorantes-Cuéllar A, Martínez-Sibaja C. Endocrinología clínica. Editorial Manual Moderno. 3a ed. 2008.

  15. Balthazar-González V. Estudio del paciente con talla baja. Medicina & Laboratorio 1996; 6: 41- 50.

  16. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008; 18: 89-110.

  17. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Vol. 2. Stanford University Press. Stanford, CA. 1959.

  18. Hamilton J, Blaser S, Daneman D. MR imaging in idiopathic growth hormone deficiency. AJNR Am J Neuroradiol 1998; 19: 1609-1615.

  19. Radovick S, MacGillivray MH. Pediatric endocrinology: A practical clinical guide. Humana Press. New Jersey, 2003.

  20. Albertsson-Wikland K, Rosberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988; 67: 493-500.

  21. Pandian R, Nakamoto JM. Rational use of the laboratory for childhood and adult growth hormone deficiency. Clin Lab Med 2004; 24: 141-174.

  22. Laron Z. Usefulness of the growth hormone-releasing hormone test regardless of which fragment is used (GHRH 1-44, 1-40 or 1-29). Isr J Med Sci 1991; 27: 343-345.

  23. Cornblath M, Parker ML, Reisner SH, Forbes AE, Daughaday WH. Secretion and Metabolism of Growth Hormone in Premature and Full-Term Infants. J Clin Endocrinol Metab 1965; 25: 209- 218.

  24. de Zegher F, Devlieger H, Veldhuis JD. Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. J Clin Endocrinol Metab 1993; 76: 1177-1181.

  25. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001; 11: 137- 165.

  26. Wikland KA, Kristrom B, Rosberg S, Svensson B, Nierop AF. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 2000; 48: 475- 484.

  27. Kerrigan JR, Martha PM, Jr., Blizzard RM, Christie CM, Rogol AD. Variations of pulsatile growth hormone release in healthy short prepubertal boys. Pediatr Res 1990; 28: 11-14.

  28. Saini S, Hindmarsh PC, Matthews DR, Pringle PJ, Jones J, Preece MA, et al. Reproducibility of 24-hour serum growth hormone profiles in man. Clin Endocrinol (Oxf) 1991; 34: 455-462.

  29. Lanes R. Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children. Am J Dis Child 1989; 143: 1284-1286.

  30. Hourd P, Edwards R. Current methods for the measurement of growth hormone in urine. Clin Endocrinol (Oxf) 1994; 40: 155-170.

  31. Phillip M, Chalew SA, Stene MA, Kowarski AA. The value of urinary growth hormone determination for assessment of growth hormone deficiency and compliance with growth hormone therapy. Am J Dis Child 1993; 147: 553-557.

  32. Albini CH, Quattrin T, Vandlen RL, MacGillivray MH. Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res 1988; 23: 89-92.

  33. Georges P, Liefooghe J, Ponchaux D, Forzy G, Di Nicola L, Chaussain JL. Urinary growth hormone excretion: results of a multicenter study in France. Horm Res 1997; 47: 30-37.

  34. Pirazzoli P, Mandini M, Zucchini S, Gualandi S, Vignutelli L, Capelli M, et al. Urinary growth hormone estimation in diagnosing severe growth hormone deficiency. Arch Dis Child 1996; 75: 228-231.

  35. Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 531-535.

  36. Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19: 203- 223.

  37. Reiter EO, Lovinger RD. The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth. J Pediatr 1981; 99: 720-724.

  38. Rosenfeld RG. Is growth hormone deficiency a viable diagnosis? J Clin Endocrinol Metab 1997; 82: 349-351.

  39. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752.

  40. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 2003; 60: 53- 60.

  41. Yamanaka Y, Fowlkes JL, Wilson EM, Rosenfeld RG, Oh Y. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 1999; 140: 1319-1328.

  42. Martin JL, Baxter RC. Insulin-like growth factorbinding protein from human plasma. Purification and characterization. J Biol Chem 1986; 261: 8754-8760.

  43. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin- binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-1298.

  44. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, et al. Usefulness and limitation of measurement of insulin-like growth factor binding protein-3 (IGFBP-3) for diagnosis of growth hormone deficiency. Endocrinol Jpn 1992; 39: 585-591.

  45. Sklar C, Sarafoglou K, Whittam E. Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 1993; 129: 511-515.

  46. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulinlike growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993; 77: 1294-1299.

  47. Sperling M. Disorders of growth hormone/insulinlike growth factor secretion and action. In: Pediatric Endocrinology. 3a ed. 2008. 254-334.

  48. Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, et al. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 2001; 86: 1574-1579.

  49. Nagel BH, Palmbach M, Petersen D, Ranke MB. Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. Eur J Pediatr 1997; 156: 758-763.

  50. Sheppard MC. Growth hormone assay standardization: an important clinical advance. Clin Endocrinol (Oxf) 2007; 66: 157-161.

  51. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003; 143: 415-421.

  52. Gil-Ad I, Topper E, Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet 1979; 2: 278-279.

  53. Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Razafindraibe H, et al. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep. Endocrinology 1994; 134: 562-567.

  54. Laron Z, Mannheimer S, Nitzan M, Goldman J. Growth hormone, glucose, and free fatty acid levels in mother and infant in normal, diabetic and toxaemic pregnancies. Arch Dis Child 1967; 42: 24-28.

  55. Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab 1997; 82: 2117-2121.

  56. Loche S, Cappa M, Borrelli P, Faedda A, Crino A, Cella SG, et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin- C mediated inhibition. Clin Endocrinol (Oxf) 1987; 27: 145-153.

  57. Weldon VV, Gupta SK, Klingensmith G, Clarke WL, Duck SC, Haymond MW, et al. Evaluation of growth hormone release in children using arginine and L-dopa in combination. J Pediatr 1975; 87: 540-544.

  58. Merimee TJ, Rabinowtitz D, Fineberg SE. Arginine- initiated release of human growth hormone. Factors modifying the response in normal man. N Engl J Med 1969; 280: 1434-1438.

  59. Penny R, Blizzard RM, Davis WT. Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab 1969; 29: 1499-1501.

  60. Iovino M, Monteleone P, Steardo L. Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man. J Clin Endocrinol Metab 1988; 66: 217-220.

  61. Hanew K, Utsumi A. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa- induced GH release in normal subjects. Eur J Endocrinol 2002; 146: 197-202.

  62. Gale EA, Bennett T, Macdonald IA, Holst JJ, Matthews JA. The physiological effects of insulin- induced hypoglycaemia in man: responses at differing levels of blood glucose. Clin Sci (Lond) 1983; 65: 263-271.

  63. Ranke MB. Diagnosis of growth hormone deficiency and growth hormone stimulation tests. In: Ranke, MB, ed. Diagnosis of endocrine function in children and adolescents. 3a ed. Basilea, Karger, 2003: 107-128.

  64. Mitchell ML, Byrne MJ, Sanchez Y, Sawin CT. Detecon of growth-hormone deficiency. N Engl J Med 1970; 282: 539-541.

  65. Chanoine JP, Rebuffat E, Kahn A, Bergmann P, Van Vliet G. Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5-12 months. J Clin Endocrinol Metab 1995; 80: 3032-3035.

  66. Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, et al. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. J Clin Endocrinol Metab 1986; 63: 174-179.

  67. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996; 81: 3323-3327.

  68. Rosenfeld RG. Evaluation of growth and maturation in adolescence. Pediatr Rev 1982; 4: 175-183.

  69. Deller JJ, Jr., Boulis MW, Harriss WE, Hutsell TC, Garcia JF, Linfoot JA. Growth hormone response patterns to sex hormone administration in growth retardation. Am J Med Sci 1970; 259: 292-297.

  70. Martin LG, Clark JW, Connor TB. Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab 1968; 28: 425-428.

  71. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB, Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994; 79: 537-541.

  72. Greene SA, Torresani T, Prader A. Growth hormone response to a standardised exercise test in relation to puberty and stature. Arch Dis Child 1987; 62: 53-56.

  73. Donaubauer J, Kratzsch J, Fritzsch C, Stach B, Kiess W, Keller E. The treadmill exhausting test is not suitable for screening of growth hormone deficiency! Horm Res 2001; 55: 137-140.




2020     |     www.medigraphic.com